CureApp Digital Therapeutic For Hypertension Receives Insurance Coverage, Begins Sales To Medical Institutions Across Japan

CureApp, Inc. announced the start of insurance coverage for its CureApp HT Hypertension Adjunctive Treatment App (CureApp HT), a DTx*1 solution treating hypertension, in Japan from September 1, 2022. Looking ahead, the app will be prescribed and provided to patients with hypertension as a health insurance treatment at medical institutions.

After confirming the efficacy and safety of CureApp HT through clinical trials, the results of a Japanese Phase III domestic multicenter randomized controlled trial were published in EHJ, one of the most well-respected peer reviewed journals in the world in 2021. In April 2022, CureApp HT was the . . .